Acquisition of a private financial investor

In 2005-2006, we provided financial advisory services for Polski Bank Komórek Macierzystych S.A., as a result of which the Company acquired a private equity investor and funds for development purposes.
The transaction value was not made public.

Polski Bank Komórek Macierzystych S.A. has been operating in the international market under the FamiCord Group brand since 2002. Its main activity consists in the acquisition, processing, and long-term storage of stem cells collected from umbilical cord blood. The goal of Polski Bank Komórek Macierzystych S.A. is to provide the family with access to the child’s stem cells in case of medical necessity. Polski Bank Komórek Macierzystych S.A. was listed on the WSE from 2016 to 2022.

The FamiCord Group operates directly in Poland, Spain, Turkey, Latvia, Hungary, Romania, Italy, and through business partners in Sweden, Ukraine, Serbia, and the United Kingdom. In terms of the number of newly acquired samples, it is the No. 1 bank in Europe and one of the largest in terms of total units in stock. In addition, the Group is investing in the development of services for the manufacture of advanced therapy medicinal products (ATMPs), considered one of the most important developments in medicine.

Service: Raising capital and investors

Client:

POLSKI BANK KOMÓREK
MACIERZYSTYCH S.A.